Filing Details

Accession Number:
0001181431-13-048596
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-11 16:05:31
Reporting Period:
2013-09-09
Filing Date:
2013-09-11
Accepted Time:
2013-09-11 16:05:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224110 F Robert Friel 940 Winter Street
Waltham MA 02451
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-09 70,500 $16.44 587,349 No 4 M Direct
Common Stock Disposition 2013-09-09 70,500 $37.20 516,849 No 4 S Direct
Common Stock Acquisiton 2013-09-10 70,500 $16.44 587,349 No 4 M Direct
Common Stock Disposition 2013-09-10 70,500 $37.69 516,849 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2013-09-09 70,500 $0.00 70,500 $16.44
Common Stock NQ Stock Option (right to buy) Disposition 2013-09-10 70,500 $0.00 70,500 $16.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,500 2013-10-22 No 4 M Direct
0 2013-10-22 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on August 8, 2013.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $37.000 to $37.460. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $37.540 to $37.910. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. This option became exercisable in four equal annual installments beginning on October 22, 2004, which was the first anniversary of the date on which the option was granted.